Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Strengthening and utilizing response groups for emergencies flagship: a narrative review of the roll out process and lessons from the first year of implementation.
Conteh INM, Braka F, Assefa EZ, Daniel EO, Ngofa RO, Okeibunor JC, Omony OE, Hakizimana JL, Wondimagegnehu A, Djingarey MH, Kobie AG, Kirigia DG, Mbasha JJ, Fekadu ST, Aderinola OM, Ahmat A, Asamani JA, Pallawo RB, Mpia LM, Diaw M, Kourouma M, Davi K, Condé S, Moakofhi K, Balami KY, Okamura M, De Wee RJ, Joseph G, Saguti GE, Andemichael GR, Abok P, Avwerhota M, Livinus MC, Okoronwanja HA, Makayoto L, Rutagengwa A, Ba MM, Kandako Y, Livinus PM, Diallo AM, Tengomo GLF, Belizaire MRD, Daizo A, Muzi B, Yam A, Ramadan OPC, D'khil LMM, Bonkoungou B, O'malley H, Gueye AS. Conteh INM, et al. Among authors: de wee rj. Front Public Health. 2024 May 15;12:1405174. doi: 10.3389/fpubh.2024.1405174. eCollection 2024. Front Public Health. 2024. PMID: 38818451 Free PMC article. Review.
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Brown DM, Boyer DS, Do DV, Wykoff CC, Sakamoto T, Win P, Joshi S, Salehi-Had H, Seres A, Berliner AJ, Leal S, Vitti R, Chu KW, Reed K, Rao R, Cheng Y, Sun W, Voronca D, Bhore R, Schmidt-Ott U, Schmelter T, Schulze A, Zhang X, Hirshberg B, Yancopoulos GD, Sivaprasad S; PHOTON Investigators. Brown DM, et al. Lancet. 2024 Mar 23;403(10432):1153-1163. doi: 10.1016/S0140-6736(23)02577-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461843 Clinical Trial.
Full-length single-molecule protein fingerprinting.
Filius M, van Wee R, de Lannoy C, Westerlaken I, Li Z, Kim SH, de Agrela Pinto C, Wu Y, Boons GJ, Pabst M, de Ridder D, Joo C. Filius M, et al. Among authors: van wee r. Nat Nanotechnol. 2024 May;19(5):652-659. doi: 10.1038/s41565-023-01598-7. Epub 2024 Feb 13. Nat Nanotechnol. 2024. PMID: 38351230
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
Single-Molecule FRET X.
Filius M, van Wee R, Joo C. Filius M, et al. Among authors: van wee r. Methods Mol Biol. 2024;2694:203-213. doi: 10.1007/978-1-0716-3377-9_10. Methods Mol Biol. 2024. PMID: 37824006
86 results